BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36761898)

  • 1. Follow-up value of serum AFP and aminotransferases in chronic hepatitis B progression.
    Yu M; Huang L; Zhang S; Jiang L; Jin Y; Gu M; Liao J; Zhang J
    Front Cell Infect Microbiol; 2023; 13():1082390. PubMed ID: 36761898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of α-fetoprotein levels with liver stiffness measurement in outpatients with chronic hepatitis B.
    Wang J; Zhang P; Liao J; Zhu Y; Liu X; Tang H
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33289529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
    Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
    J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combination of serum oligosaccharide chain (G-test), alpha-fetoprotein, and aspartate aminotransferase to alanine aminotransferase ratio provides the optimal diagnostic value for early detection of hepatocellular carcinoma.
    Zhu W; Shi P; Liang A; Zhu Y; Fu J; Yuan S; Wu X
    BMC Cancer; 2022 Oct; 22(1):1061. PubMed ID: 36241994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic fibrosis and serum alpha-fetoprotein (AFP) as predictors of response to HCV treatment and factors associated with serum AFP normalisation after treatment.
    El Raziky M; Attia D; El Akel W; Shaker O; Khatab H; Abdo S; Elsharkawy A; Esmat G
    Arab J Gastroenterol; 2013 Sep; 14(3):94-8. PubMed ID: 24206736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-fetoprotein level as a biomarker of liver fibrosis status: a cross-sectional study of 619 consecutive patients with chronic hepatitis B.
    Liu YR; Lin BB; Zeng DW; Zhu YY; Chen J; Zheng Q; Dong J; Jiang JJ
    BMC Gastroenterol; 2014 Aug; 14():145. PubMed ID: 25128299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A randomized controlled trial on 240-week monotherapy with entecavir or adefovir in patients with chronic hepatitis B and cirrhosis].
    Lian J; Han T; Xiang H; Liu F; Lyu H; Gao Y; Wang F
    Zhonghua Gan Zang Bing Za Zhi; 2015 Oct; 23(10):733-7. PubMed ID: 26573188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of non-invasive models of liver fibrosis in judgment of treatment timing in chronic hepatitis B patients with ALT < 2×upper limit of normal].
    Zhou QQ; Hu YB; Zhou K; Zhang WW; Li MH; Dong P; Di JG; Hong L; Du QW; Xie Y; Sun QF
    Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):665-670. PubMed ID: 27788722
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation of liver biochemistry with liver stiffness in chronic hepatitis B and development of a predictive model for liver fibrosis.
    Fung J; Lai CL; Fong DY; Yuen JC; Wong DK; Yuen MF
    Liver Int; 2008 Dec; 28(10):1408-16. PubMed ID: 18482268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare.
    Han Y; Tang Q; Zhu W; Zhang X; You L
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1728-33. PubMed ID: 18823435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor 7 mRNA is reduced in hepatitis C-based liver cirrhosis and hepatocellular carcinoma, out-performs alpha-fetoprotein levels, and with age and serum aspartate aminotransferase is a new diagnostic index.
    Mohamed AA; Omran D; El-Feky S; Darwish H; Kassas A; Farouk A; Ezzat O; Abdo SM; Zahran FE; El-Demery A; Omran MM
    Br J Biomed Sci; 2021 Jan; 78(1):18-22. PubMed ID: 32573389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ambulatory end-stage liver disease in Ghana; patient profile and utility of alpha fetoprotein and aspartate aminotransferase: platelet ratio index.
    Nartey YA; Awuku YA; Agyei-Nkansah A; Duah A; Bampoh SA; Ayawin J; Asibey SO; Björkström NK; Ye W; Afihene MY; Roberts LR; Plymoth A
    BMC Gastroenterol; 2020 Dec; 20(1):428. PubMed ID: 33357229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.
    Ungtrakul T; Mahidol C; Chun-On P; Laohapand C; Siripongsakun S; Worakitsitisatorn A; Vidhayakorn S; Boonchuay W; Dechma J; Sornsamdang G; Soonklang K; Sriprayoon T; Tanwandee T; Auewarakul CU
    World J Gastroenterol; 2016 Sep; 22(34):7806-12. PubMed ID: 27678364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic value of non-invasive tests for the evaluation of liver fibrosis in chronic hepatitis B patients.
    Erdogan S; Dogan HO; Sezer S; Uysal S; Ozhamam E; Kayacetin S; Koca Y
    Scand J Clin Lab Invest; 2013; 73(4):300-8. PubMed ID: 23514016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of inflammatory score/liver function and AFP improves the diagnostic accuracy of HBV-related hepatocellular carcinoma.
    Ding Y; Liu K; Xu Y; Zhao Q; Lou S; Xiang X; Yan L; Cao Z; Xie Q; Zhu C; Bao S; Wang H
    Cancer Med; 2020 May; 9(9):3057-3069. PubMed ID: 32150664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapy.
    Liu R; Guo J; Lu Y; Zhang L; Shen G; Wu S; Chang M; Hu L; Hao H; Li M; Xie Y
    Clin Exp Med; 2019 Aug; 19(3):309-320. PubMed ID: 31111345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel biomarkers for the management of chronic hepatitis B.
    Inoue T; Tanaka Y
    Clin Mol Hepatol; 2020 Jul; 26(3):261-279. PubMed ID: 32536045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ultrasonic scores combined with blood indexes for screening and predicting compensated liver cirrhosis in chronic hepatitis B patients].
    Chen YP; Hou JL; Dai L; Wang JL; Zhu YF
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec; 28(12):2157-60. PubMed ID: 19114345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-body insulin resistance is associated with elevated serum α-fetoprotein levels in patients with chronic hepatitis C.
    Kawaguchi Y; Mizuta T; Eguchi Y; Sakurai E; Motomura Y; Isoda H; Kuwashiro T; Oeda S; Iwane S; Takahashi H; Anzai K; Ozaki I
    Intern Med; 2013; 52(21):2393-400. PubMed ID: 24190142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B in hepatocellular carcinoma patients and its correlation with alpha-fetoprotein and liver enzymes.
    Surit R; Shekhar R; Sinha DK; Singh SK; Kumar U; Prasad N
    J Cancer Res Ther; 2022; 18(4):903-906. PubMed ID: 36149138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.